APA (7th ed.) Citation

Grover, P., Tang, C., Jacques, A., Kernutt, E., Dass, J., Dewar, J., . . . Lim, A. M. (2025). A two-phase study investigating the quality of life benefit of additional 0.5% cocaine mouthwash to institutional standard of care mucositis management in head and neck cancer patients undergoing radiotherapy or chemoradiotherapy. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14955-7

Chicago Style (17th ed.) Citation

Grover, Piyush, Colin Tang, Angela Jacques, Elizabeth Kernutt, Joshua Dass, Joanna Dewar, Rohen White, and Annette M. Lim. "A Two-phase Study Investigating the Quality of Life Benefit of Additional 0.5% Cocaine Mouthwash to Institutional Standard of Care Mucositis Management in Head and Neck Cancer Patients Undergoing Radiotherapy or Chemoradiotherapy." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14955-7.

MLA (9th ed.) Citation

Grover, Piyush, et al. "A Two-phase Study Investigating the Quality of Life Benefit of Additional 0.5% Cocaine Mouthwash to Institutional Standard of Care Mucositis Management in Head and Neck Cancer Patients Undergoing Radiotherapy or Chemoradiotherapy." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14955-7.